Enrico Ferro, MD, Awarded Youth Investigator Award at EHRA 2026

At the recent European Heart Rhythm Association (EHRA) Congress, Enrico Ferro’s work drew recognition for contributing to new insights on pulsed field ablation (PFA) versus traditional radiofrequency (RF) ablation in patients with atrial fibrillation.

Findings reported by TCTMD and Cardiovascular Business highlighted that, while PFA remains a promising next-generation ablation technology due to its tissue selectivity and safety advantages, emerging data suggest a potentially higher risk of stroke compared with RF ablation in certain settings. These results add important nuance to the rapidly evolving evaluation of PFA as its clinical use expands.

Ferro’s role in this research underscores his involvement in advancing electrophysiology and in critically assessing innovative therapies. The attention at EHRA reflects growing scientific interest in balancing the benefits of new ablation technologies with a thorough understanding of their risks, ultimately aiming to optimize outcomes for patients with atrial fibrillation.

PFA associated with heightened stroke risk

Higher Stroke Risk Seen With Pulsed-Field vs Radiofrequency Ablation | tctmd.com